Accès à distance ? S'identifier sur le proxy UCLouvain
Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. : The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Poster |
|---|---|
| Access type | Accès restreint |
| Publication date | 2009 |
| Language | Anglais |
| Conference | "15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology", Berlin(Germany) (du 20/09/2009 au 24/09/2009) |
| Journal information | "EJC - Supplements" - Vol. 7, no. 2, p. 138-139 (2009) |
| Peer reviewed | yes |
| issn | 1359-6349 |
| Publisher | Pergamon (Oxford) |
| Publication status | Publié |
| Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Unité d'oncologie médicale UCL - (SLuc) Centre du cancer |
| Links |
| Bibliographic reference | Schöffski, Patrick ; Blay, J. Y. ; De Greve, J. ; Brain, E. ; Machiels, Jean-Pascal ; et. al. Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. : The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI).15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (Berlin(Germany), du 20/09/2009 au 24/09/2009). In: EJC - Supplements, Vol. 7, no. 2, p. 138-139 (2009) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/58661 |